Results 161 to 170 of about 26,553 (248)

Recombinant Oncolytic Viruses: Hexagonal Warriors in the Field of Solid Tumor Immunotherapy. [PDF]

Curr Issues Mol Biol
Zhang C, Sun Q.
europepmc   +1 more source

Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses. [PDF]

Front Immunol
Omolekan TO, Folahan JT, Tesfay MZ, Mohan H, Dutta O, Rahimian L, Ferdous KU, Ghavimi R, Cios A, Beng TK, Francis J, D'Auvergne O, Borad MJ, Kousoulas KG, DiGiuseppe S, Nagalo BM, Chamcheu JC.   +16 more
europepmc   +1 more source

Oncolytic viruses targeting CD47: a new road to success? [PDF]

J Immunother Cancer
Takimoto CH, Wick MJ.
europepmc   +1 more source

Design and Efficacy of Oncolytic Viruses and Antitumor Vaccines: A Dead End in the Immunotherapy of Pancreatic Cancer? [PDF]

Int J Mol Sci
Achim E, Pîrlici E, Cristea C, Tertis M.   +3 more
europepmc   +1 more source

Advancements on the synergistic application of oncolytic viruses and molecularly targeted therapies for the treatment of solid tumors (Review). [PDF]

Int J Oncol
Bi S, Shan T, Tang Y, Wang Q.
europepmc   +1 more source

Next-Generation Oncolytic Viruses to Overcome Resistance to Anti-PD-1 Therapy in Melanoma. [PDF]

J Clin Oncol
McArthur GA.
europepmc   +1 more source

Oncolytic viruses cancer therapy

, 2008
Wild-type viruses with intrinsic oncolytic capacity in human includes DNA viruses like some autonomous parvoviruses and many RNA viruses. Recent advances in molecular biology have allowed the design of several genetically modified viruses, such as adenovirus and herpes simplex virus that specifically replicate in, and kill tumor cells.
openaire   +1 more source

Hydrogel Micro/Nanostructures for the Delivery of Oncolytic Viruses: Overcoming Limitations and Improving Efficacy. [PDF]

Adv Pharm Bull
Hsu CY, Jasim SA, Rizaev JA, Basunduwah TS, Abbot V, Chahar M, Asiri M, Ali AF, Yumashev A, Zwamel AH.   +9 more
europepmc   +1 more source

Going viral: targeting glioblastoma using oncolytic viruses. [PDF]

Immunother Adv
Coates K, Nibbs RJ, Fraser AR.
europepmc   +1 more source

A new strategy for melanoma treatment: an investigation of the clinical value of the combination of immune checkpoint inhibitors and oncolytic viruses. [PDF]

Cancer Cell Int
Sui B, Jin X, Zheng X.
europepmc   +1 more source